Black Rock Inc. Igm Biosciences, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 757,963 shares of IGMS stock, worth $6.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

757,963

Previous 762,470 0.59%

Holding current value

$6.31 Million

Previous $6.34 Million 15.44%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$8.68 - $17.36 $39,120 - $78,241	-4,507 Reduced 0.59%	757,963 $7.31 Million
Q4 2023 Feb 13, 2024	SELL	$3.94 - $8.79 $427,277 - $953,240	-108,446 Reduced 12.45%	762,470 $6.34 Million
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $91,541 - $146,246	13,745 Added 1.6%	870,916 $7.27 Million
Q2 2023 Aug 11, 2023	BUY	$8.86 - $14.0 $767,054 - $1.21 Million	86,575 Added 11.23%	857,171 $7.91 Million
Q1 2023 May 12, 2023	SELL	$13.74 - $25.76 $256,099 - $480,140	-18,639 Reduced 2.36%	770,596 $10.6 Million

Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $761,731 - $1.28 Million	49,303 Added 6.66%	789,235 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $250,143 - $438,156	16,222 Added 2.24%	739,932 $16.8 Million
Q2 2022 Aug 12, 2022	BUY	$13.27 - $25.5 $383,317 - $736,593	28,886 Added 4.16%	723,710 $13 Million
Q1 2022 May 12, 2022	BUY	$13.42 - $29.73 $239,775 - $531,185	17,867 Added 2.64%	694,824 $18.6 Million
Q4 2021 Feb 10, 2022	BUY	$27.59 - $66.39 $999,309 - $2.4 Million	36,220 Added 5.65%	676,957 $19.9 Million
Q3 2021 Nov 09, 2021	BUY	$65.76 - $90.65 $521,871 - $719,398	7,936 Added 1.25%	640,737 $42.1 Million
Q2 2021 Aug 11, 2021	BUY	$57.98 - $96.6 $36.7 Million - $61.1 Million	632,801 New	632,801 $52.7 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.5M

Call Options Held

11.1K

Put Options Held

5.1K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $241M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account